NKTR Latest Headlines

Nektar Therapeutics (NKTR) Gets a Buy from Canaccord Genuity

at www.tipranks.com (Thu, 6-Aug 7:08 AM)

Nektar’s Phase 3 Eczema Trial Moves Forward: What Investors Should Watch

at www.tipranks.com (Tue, 4-Aug 12:31 PM)

Nektar Therapeutics to Announce Q2 Results on August 13—Upcoming Earnings Call Brings Pipeline Focus Into Spotlight

Market Chameleon (Wed, 29-Jul 9:30 AM)

Nektar Therapeutics Launches Phase 3 ZENITH AD Trials—Rezpegaldesleukin Shows Promise in Hard-to-Treat Atopic Dermatitis

Market Chameleon (Tue, 21-Jul 9:44 AM)